The group reported lower revenue for the quarter due to lower sales in beer, non-alcoholic beverages and food businesses.

Hyphens Pharma has completed the second tranche of acquiring 17% of shares in Ardence Pharm for a consideration of $3.35 ...

STI remains on track to move progressively higher despite elevated 10-year US treasury yield as local 10 year SGS yields ...